1.24
Finanzdaten der Vivos Therapeutics Inc-Aktie (VVOS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
77.57%
6.783
|
3.82 | 3.016 | 4.054 | 3.419 |
| Cost Of Revenue |
66.43%
2.846
|
1.71 | 1.507 | 1.403 | 0.10 |
| Gross Profit |
86.59%
3.937
|
2.11 | 1.509 | 2.651 | 1.937 |
| Operating Expenses |
24.32%
8.671
|
6.975 | 5.427 | 4.587 | 5.722 |
| Interest Income/Expense |
0.50
|
- | - | - | - |
| Benefits Costs and Expenses |
37.93%
12.18
|
8.833 | 6.88 | 5.984 | 7.182 |
| Costs And Expenses |
37.93%
12.18
|
8.833 | 6.88 | 5.984 | 7.182 |
| Depreciation and Amortization |
25.49%
0.384
|
0.306 | 0.177 | 0.145 | 0.146 |
| Operating Income/Loss |
2.69%
-4.734
|
-4.865 | -3.918 | -1.936 | -3.785 |
| Income/Loss From Continuing Operations Before Tax |
7.72%
-5.40
|
-5.013 | -3.864 | -1.93 | -3.763 |
| Income/Loss From Continuing Operations After Tax |
7.72%
-5.40
|
-5.013 | -3.864 | -1.93 | -3.763 |
|
|
7.72%
-5.40
|
-5.013 | -3.864 | -1.93 | -3.763 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
20.65%
10.96
|
9.0872 | 8.5953 | 3.2284 | 2.3082 |
| Diluted Average Shares |
20.65%
10.96
|
9.0872 | 8.5953 | 3.2284 | 2.3082 |
| Basic Earnings Per Share |
10.91%
-0.49
|
-0.55 | -0.45 | -0.60 | -1.63 |
| Diluted Earnings Per Share |
10.91%
-0.49
|
-0.55 | -0.45 | -0.60 | -1.63 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):